浙江廣廈(600052.SH):擬以1.56億元購買正藍節能50.54%股份
格隆匯7月28日丨浙江廣廈(600052.SH)公佈,為進一步優化公司業務結構,降低業績波動性,提升公司抗風險能力和持續經營能力,作為公司轉型的嘗試及現有影視業務的補充,公司擬通過全國股轉系統,採用集合競價交易和盤後大宗交易相結合的方式向王娟娟、許根華、張玉賀、盧軍紅、杭州雨沐股權投資合夥企業(有限合夥)(“雨沐投資”)、河北集結號投資管理有限公司(“河北集結號”)、趙雲池、蔣姚忠、劉方盛、彭立華購買其合計持有的浙江正藍節能科技股份有限公司(“正藍節能”)50.54%股份。
經交易各方協商,該次擬交易的正藍節能50.54%股份交易總對價約為1.56億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.